The home of the Audio Journal of Oncology
David Cameron

UK TACT2 trial confirms chemotherapy is highly effective in early beast cancer

AudioMedica News
AudioMedica News
UK TACT2 trial confirms chemotherapy is highly effective in early beast cancer
UK TACT2 trial confirms chemotherapy is highly effective in early beast cancer
/

SAN ANTONIO, TEXAS—The UK TACT2 trial, looking at over 4 000 patients with early breast cancer, has confirmed that modern chemotherapy is very effective, and continues to contribute to very high cure rates. Professor David Cameron of Edinburgh University explains the importance of this study.



LISTEN

[audio:https://www.audiomedica.com/podcasting/oncology/121206DavidCameronPODCASTLoRes.mp3]

Further reading

Sign up for AudioMedica.com news

* = required field
Speciality